Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease

Clinical Endocrinology

Volumn 77, Issue 4, 2012, Pages 621-627

  Martin, Niamh M ^a,b   Patel, Miraj ^b   Nijher, Gurjinder M K ^a,b   Misra, Shivani ^a,b   Murphy, Elaine ^b   Meeran, Karim ^a,b  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIMAZOLE; LIOTHYRONINE; LITHIUM CARBONATE; PREDNISOLONE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THYROTROPIN; THYROXINE;

ADJUVANT THERAPY; ADULT; ARTICLE; COHORT ANALYSIS; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; ENDOCRINE OPHTHALMOPATHY; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID ADENOMA; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; TOXIC GOITER; TREATMENT DURATION;

ADULT; FEMALE; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; LITHIUM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84867316394     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04385.x     Document Type: Article

References (21)

1. Becker, D.V. & Sawin, C.T. (1996) Radioiodine and thyroid disease: the beginning. Seminars in Nuclear Medicine, 26, 155-164.
2. Allahabadia, A., Daykin, J., Sheppard, M.C. et al. (2001) Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. Journal of Clinical Endocrinology & Metabolism, 86, 3611-3617.
3. Metso, S., Jaatinen, P., Huhtala, H. et al. (2004) Long-term follow- up study of radioiodine treatment of hyperthyroidism. Clinical Endocrinology, 61, 641-648.
4. Boelaert, K., Syed, A.A., Manji, N. et al. (2009) Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism. Clinical Endocrinology, 70, 129-138.
5. Alexander, E.K. & Larsen, P.R. (2002) High dose 131I therapy for the treatment of hyperthyroidism caused by Graves' disease. Journal of Clinical Endocrinology & Metabolism, 87, 1073-1077.
6. Nordyke, R.A. & Gilbert Jr, F.I. (1991) Optimal Iodine-131 dose for eliminating hyperthyroidism in Graves' disease. Journal of Nuclear Medicine, 32, 411-416.
7. Leslie, W.D., Ward, L., Salamon, E.A. et al. (2003) A randomized comparison of radioiodine doses in Graves' hyperthyroidism. Journal of Clinical Endocrinology & Metabolism, 88, 978-983.
8. Turner, J.G., Brownlie, B.E.W. & Rogers, T.G.H. (1976) Lithium as an adjunct to radioiodine therapy for thyrotoxicosis. The Lancet, 307, 614-615.
9. Lazarus, J.H. (2009) Lithium and thyroid. Best Practice & Research Clinical Endocrinology & Metabolism, 23, 723-733.
10. Robbins, J. (1984) Perturbations of iodine metabolism by lithium. Mathematical Biosciences, 72, 337-347.
11. Temple, R., Berman, M., Robbins, J. et al. (1972) The use of lithium in the treatment of thyrotoxicosis. Journal of Clinical Investigation, 51, 2746-2756.
12. Mori, M., Tajima, K., Oda, Y. et al. (1989) Inhibitory effect of lithium on the release of thyroid hormones from thyrotropinstimulated mouse thyroids in a perifusion system. Endocrinology, 124, 1365-1369.
13. Bogazzi, F., Bartalena, L., Brogioni, S. et al. (1999) Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism. Journal of Clinical Endocrinology & Metabolism, 84, 499-503.
14. Bogazzi, F., Bartalena, L., Campomori, A. et al. (2002) Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease. Journal of Clinical Endocrinology & Metabolism, 87, 4490-4495.
15. Vannucchi, G., Chiti, A., Mannavola, D. et al. (2005) Radioiodine treatment of non-toxic multinodular goitre: effects of combination with lithium. European Journal of Nuclear Medicine and Molecular Imaging, 32, 1081-1088.
16. Bal, C.S., Kumar, A. & Pandey, R.M. (2002) A randomized controlled trial to evaluate the adjuvant effect of lithium on radioiodine treatment of hyperthyroidism. Thyroid, 12, 399-405.
17. Bogazzi, F., Giovannetti, C., Fessehatsion, R. et al. (2010) Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal. Journal of Clinical Endocrinology & Metabolism, 95, 201-208.
18. Royal College of Physicians. (2007) Radioiodine in the Management of Benign Thyroid Disease: Clinical Guidelines. Report of a Working Party. RCP, London.
19. Benker, G., Reinwein, D., Kahaly, G. et al. (1998) Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. Clinical Endocrinology, 49, 451-457.
20. Plazinska, M.T., Krolicki, L. & Bak, M. (2011) Lithium carbonate pre-treatment in 131-I therapy of hyperthyroidism. Nuclear Medicine Review Central and Eastern Europe, 14, 3-8.
21. Bartalena, L., Marcocci, C., Bogazzi, F. et al. (1998) Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. New England Journal of Medicine, 338, 73-78.